Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2021	Jun. 30, 2021
Current assets:
Cash and cash equivalents		$ 123,196	$ 116,369
Restricted cash		244	560
Accounts receivable, net of allowance for credit losses of $1,199 and $1,048 as of December 31, 2021 and June 30, 2021, respectively	[1]	81,905	85,360
Inventories		123,680	125,929
Prepaid expenses and other current assets	[2]	20,940	21,547
Deferred cost of revenue		1,355	3,008
Total current assets		351,320	352,773
Property and equipment, net		12,208	12,332
Investment in joint venture		14,678	15,935
Operating lease right-of-use assets, net		19,429	22,522
Goodwill		58,006	57,960
Intangible assets, net		322	435
Restricted cash		1,256	1,272
Other assets		18,282	16,869
Total assets		475,501	480,098
Current liabilities:
Accounts payable		29,258	19,467
Accrued compensation		24,184	26,865
Operating lease liabilities, current		8,327	8,169
Other accrued liabilities		33,883	27,471
Customer advances		24,610	24,937
Deferred revenue		76,585	81,660
Short-term debt		7,541	3,790
Total current liabilities		204,388	192,359
Long-term liabilities:
Operating lease liabilities, non-current		13,756	17,441
Long-term other liabilities		6,696	7,766
Deferred revenue		25,175	23,685
Long-term debt		174,492	170,007
Total liabilities		424,507	411,258
Commitments and contingencies (Note 9)
Stockholders' equity:
Common stock, $0.001 par value; authorized: 200,000,000 shares as of December 31, 2021 and June 30, 2021, respectively; issued and outstanding: 92,733,531 and 90,821,661 shares at December 31, 2021 and June 30, 2021, respectively		93	91
Additional paid-in-capital		536,709	554,680
Accumulated other comprehensive income		2,216	2,093
Accumulated deficit		(488,024)	(488,024)
Total stockholders' equity		50,994	68,840
Total liabilities and stockholders' equity		$ 475,501	$ 480,098

[1] Includes trade receivable from the China joint venture, an equity method investment of $11,735 and $8,822 at December 31, 2021 and June 30, 2021, respectively. See Note 14.

[2] Includes other receivable from the China joint venture, an equity method investment of $415 and $187 at December 31, 2021 and June 30, 2021, respectively.